BlackRock
LUCD icon

BlackRock’s Lucid Diagnostics LUCD Stock Holding History

BlackRock’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.96M Buy
8,373,117
+3,734,874
+81% +$4.03M ﹤0.01% 3727
2026
Q1 		$5.33M Buy
4,638,243
+325,605
+8% +$414K ﹤0.01% 3799
2025
Q4 		$4.7M Buy
4,312,638
+643,346
+18% +$719K ﹤0.01% 3858
2025
Q3 		$3.71M Buy
3,669,292
+50,969
+1% +$55.7K ﹤0.01% 3904
2025
Q2 		$4.16M Buy
3,618,323
+3,591,013
+13,149% +$4.64M ﹤0.01% 3849
2025
Q1 		$40.7K Hold
27,310
– – ﹤0.01% 4955
2024
Q4 		$22.4K Hold
27,310
– – ﹤0.01% 5088
2024
Q3 		$22.3K Hold
27,310
– – ﹤0.01% 4927
2024
Q2 		$22.4K Sell
27,310
-24,336
-47% -$20.6K ﹤0.01% 4998
2024
Q1 		$41.8K Buy
51,646
+28,193
+120% +$36.6K ﹤0.01% 4909
2023
Q4 		$33.1K Sell
23,453
-288
-1% -$380 ﹤0.01% 5025
2023
Q3 		$27.8K Sell
23,741
-2,563
-10% -$3.72K ﹤0.01% 5096
2023
Q2 		$36.6K Buy
26,304
+7,448
+39% +$11.2K ﹤0.01% 5122
2023
Q1 		$26.4K Buy
18,856
+618
+3% +$856 ﹤0.01% 5220
2022
Q4 		$24.8K Buy
18,238
+412
+2% +$741 ﹤0.01% 5350
2022
Q3 		$28K Sell
17,826
-5,115
-22% -$12.7K ﹤0.01% 5460
2022
Q2 		$52K Sell
22,941
-44,624
-66% -$99.1K ﹤0.01% 5401
2022
Q1 		$227K Buy
67,565
+10,636
+19% +$38.9K ﹤0.01% 5075
2021
Q4 		$305K Buy
+56,929
New +$462K ﹤0.01% 5007

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

BlackRock's LUCD Position: Q2 2026 in Review

BlackRock increased its Lucid Diagnostics (LUCD) stake by 81% in Q2 2026, buying an estimated $4.03M and bringing the position to 8,373,117 shares worth $8.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3727.

BlackRock first reported a position in LUCD in Q4 2021 and has held it in 19 quarters since. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • BlackRock held 8,373,117 shares of Lucid Diagnostics worth $8.96M as of Q2 2026.
  • BlackRock bought 3,734,874 Lucid Diagnostics shares in Q2 2026, an estimated $4.03M.
  • Lucid Diagnostics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3727 holding.
  • BlackRock first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 19 quarters since.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.